Oct 13, 2021 | Clinical Laboratory Proficiency Testing Services, Laboratory News, Laboratory Pathology, Laboratory Resources, Laboratory Testing, Precision Medicine
The antibodies target portions of the SARS-CoV-2 spike protein that resist mutation, potentially leading to better treatments and vaccines One challenge in the battle against COVID-19 is the emergence of SARS-CoV-2 variants, especially the Delta variant, which may be more resistant to neutralizing antibodies compared with the original coronavirus. But now, scientists led by researchers at the Fred Hutchinson Cancer Research Center (Fred Hutch) in Seattle say they have identified antibodies...